First Eagle Investment Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-219,420
| Closed | -$507K | – | 179 |
|
|
2018
Q2 | $507K | Hold |
219,420
| – | – | ﹤0.01% | 157 |
|
|
2018
Q1 | $698K | Hold |
219,420
| – | – | ﹤0.01% | 155 |
|
|
2017
Q4 | $900K | Hold |
219,420
| – | – | ﹤0.01% | 223 |
|
|
2017
Q3 | $992K | Hold |
219,420
| – | – | ﹤0.01% | 238 |
|
|
2017
Q2 | $731K | Buy |
219,420
+60,000
| +38% | +$200K | ﹤0.01% | 224 |
|
|
2017
Q1 | $1.47M | Sell |
159,420
-70,980
| -31% | -$654K | ﹤0.01% | 205 |
|
|
2016
Q4 | $1.78M | Hold |
230,400
| – | – | ﹤0.01% | 202 |
|
|
2016
Q3 | $2.63M | Buy |
230,400
+153,030
| +198% | +$1.75M | 0.01% | 209 |
|
|
2016
Q2 | $952K | Sell |
77,370
-107,060
| -58% | -$1.32M | ﹤0.01% | 252 |
|
|
2016
Q1 | $1.87M | Buy |
+184,430
| New | +$1.87M | ﹤0.01% | 208 |
|